Company intelligence / Profile preview

Jima Pharmaceutical

Suzhou, Jiangsu, China

Ownership: Private
Employees: ~280

Overview

GenePharma (also known as Jima Pharmaceutical) is a leading Chinese biotechnology company specializing in RNA-based technologies, services, and therapeutics. Founded in 2003 by Dr. Peter (Peizhuo) Zhang, the company has built a comprehensive, vertically integrated oligonucleotide platform spanning RNA monomer synthesis, custom siRNA/miRNA production, and downstream drug discovery. GenePharma operates as both a premier contract research and manufacturing organization (CRO/CMO) for nucleic acid reagents and a co-developer of innovative small nucleic acid therapeutics. Its therapeutic pipeline focuses on oncology, metabolic diseases, and chronic conditions, utilizing advanced siRNA, mRNA, and CRISPR-based technologies. Through extensive global partnerships, GenePharma supports academic research and pharmaceutical pipelines worldwide, driving the translation of RNA interference (RNAi) into clinical applications.

Modalities: Small interfering RNABiologicRNA therapymRNA-based drugsAntisense oligonucleotideAptamer
Industry: Biotech

Partnerships

Alnylam PharmaceuticalsGuangzhou Medical University Cancer HospitalUniversity of Hong KongZhejiang Chinese Medical University

Beyond the preview

Go deeper on Jima Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jima Pharmaceutical.

Explore the full profile